Occupational interstitial lung diseases from inhaled inorganic dusts.
Also known as: silicosis, asbestosis, coal worker's pneumoconiosis, CWP, black lung, berylliosis, pneumoconiosis
Overview
Group of interstitial lung diseases caused by chronic inhalation of inorganic mineral dusts in occupational settings. Major forms: silicosis (silica), asbestosis (asbestos fibers), coal worker's pneumoconiosis (coal dust), and chronic beryllium disease (beryllium — granulomatous, sarcoid-like).
Epidemiology
Resurgence of accelerated silicosis among young engineered stone (quartz) countertop workers in US/Australia. Asbestosis declining due to bans but legacy exposures persist. CWP persists in coal mining regions globally. Berylliosis in aerospace, electronics, ceramics workers.
Try two board-style Pneumoconioses questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1PulmonaryMedium
A 40-year-old sandblaster with 20 years of exposure has progressive dyspnea, upper lobe nodular opacities with eggshell calcification of mediastinal lymph nodes on CT, and restrictive pulmonary function tests (PFTs). Which of the following is the most important ongoing surveillance for this patient?
APeriodic serum BNP
BSerial calcium and angiotensin-converting enzyme (ACE) levels
CAnnual spirometry
DTuberculosis screening
Reveal answer & full explanation
Correct answer: D — Tuberculosis screening
APeriodic serum BNP
BSerial calcium and angiotensin-converting enzyme (ACE) levels
CAnnual spirometry
DTuberculosis screening✓
Why Tuberculosis screening is correct
Silicosis directly impairs macrophage function, producing a roughly 3-fold increased risk of tuberculosis (TB) reactivation
Annual interferon-gamma release assay (IGRA) or tuberculin skin test (TST) plus chest CT every 1-2 years is the recommended surveillance protocol
TB screening is the single most critical ongoing monitoring measure in patients with silicosis
Why the others are wrong
Periodic serum BNP — monitors heart failure; not a standard surveillance measure for silicosis complications (confused-with cardiac disease)
Serial calcium and angiotensin-converting enzyme (ACE) levels — used to track sarcoidosis activity, not silicosis (confused-with sarcoidosis)
Annual spirometry — pulmonary function monitoring is part of silicosis follow-up but is not the single most important surveillance measure; TB screening takes priority (right-concept-wrong-priority)
Additional high-yield points
Silicosis is caused by crystalline silica inhalation from sandblasting, mining, quarrying, and tunneling
Eggshell calcification of hilar and mediastinal lymph nodes is characteristic of silicosis (also seen in sarcoidosis)
PFTs show a restrictive pattern, sometimes with an obstructive component; DLCO is reduced
No curative treatment exists; remove from silica exposure immediately
Lung transplant is reserved for end-stage disease
Question 2PulmonaryEasy
A 42-year-old man who works in construction presents with progressive dyspnea and a dry cough over 5 years. He denies smoking. CXR shows bilateral upper lobe nodular opacities with eggshell calcification of hilar lymph nodes. Pulmonary function tests (PFTs) show a mixed obstructive and restrictive pattern. What is the most likely diagnosis?
ASilicosis
BBerylliosis
CAsbestosis
DCoal worker's pneumoconiosis
Reveal answer & full explanation
Correct answer: A — Silicosis
ASilicosis✓
BBerylliosis
CAsbestosis
DCoal worker's pneumoconiosis
Why Silicosis is correct
Silicosis is caused by inhalation of crystalline silica dust from occupations such as construction, mining, sandblasting, and quarrying
Classic CXR findings: bilateral upper lobe nodular opacities with eggshell calcification of hilar lymph nodes, which is pathognomonic for silicosis
Progressive massive fibrosis can occur
Complications include increased risk of tuberculosis (TB) (silicotuberculosis) and lung cancer
Why the others are wrong
B) Berylliosis — berylliosis is rare and resembles sarcoidosis; it does not produce eggshell calcification of hilar nodes
C) Asbestosis — asbestosis causes bilateral lower lobe interstitial fibrosis with pleural plaques, not upper lobe nodules or eggshell calcification
You've read your 2 free diagnosis previews. Create your free account to unlock the full Pneumoconioses (Silicosis, Asbestosis, Coal Worker's, Berylliosis) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Berylliosis: aerospace, nuclear, electronics, ceramic and dental laboratory work
Cumulative exposure duration and intensity drive risk; smoking synergistic for malignancy
Pathophysiology
Inhaled mineral particles reach alveoli; alveolar macrophages phagocytose but cannot digest them → chronic inflammation, fibrogenic cytokine release (TGF-beta, TNF-alpha), fibroblast proliferation, collagen deposition. Silica is the most cytotoxic and fibrogenic. Asbestos fibers (amphiboles especially) cause pleural plaques, fibrosis, and malignancy. Beryllium triggers a delayed-type hypersensitivity (CD4 T-cell) granulomatous response indistinguishable histologically from sarcoidosis.
Clinical presentation
Symptoms
Progressive exertional dyspnea (most common across all forms)
Cough — often non-productive; productive with chronic bronchitis in CWP
Chest discomfort
Constitutional symptoms in advanced disease
Asbestos: long latency (20-40 years from first exposure)
Acute silicosis: rapidly progressive dyspnea after heavy short-term exposure (engineered stone, sandblasting)
Pulmonary rehabilitation, supplemental oxygen for hypoxemia
Treat comorbid airflow obstruction (bronchodilators, ICS) in CWP
Annual TB screening (IGRA) in silicosis; treat LTBI; consider 4-drug therapy if active
Chronic beryllium disease — corticosteroids (prednisone 20-40 mg/day) for symptomatic disease, similar to sarcoidosis
Second-line / adjunct
Lung transplantation for end-stage disease in select patients
Surveillance for malignancy in asbestos-exposed: low-dose CT screening, especially with concomitant smoking; awareness for mesothelioma (insidious chest pain, pleural effusion, pleural thickening)
Whole-lung lavage for severe acute silicosis (anecdotal, specialized centers)
Antifibrotic therapy (pirfenidone, nintedanib) — emerging role for progressive pulmonary fibrosis phenotype, including occupational ILDs (PF-ILD)
Workers' compensation and occupational disease reporting
Complications
Progressive massive fibrosis (silicosis, CWP)
Tuberculosis and atypical mycobacterial infection (especially silicosis)
Lung cancer (all pneumoconioses, multiplied by smoking)
Mesothelioma (asbestos — even brief exposure; latency 20-40 years)
Engineered stone (quartz) countertops have caused a global epidemic of accelerated silicosis in young workers — high silica content + dry cutting.
Eggshell calcification of hilar lymph nodes is the classic silicosis finding.
Pleural plaques (often calcified diaphragmatic) are pathognomonic for asbestos exposure but do not require asbestosis; mesothelioma can occur without asbestosis.
Silicosis dramatically increases TB risk — screen annually with IGRA; consider isoniazid prophylaxis even with intermediate risk.
ATS 2010 — ATS Statement on Occupational Contribution to the Burden of Airway Disease (Am J Respir Crit Care Med 2003)
MMWR 2019 — Severe Silicosis in Engineered Stone Fabrication Workers — California, Colorado, Texas, and Washington, 2017-2019 (Rose et al., MMWR 2019)
Helsinki Criteria 2014 — Asbestos, Asbestosis, and Cancer — Helsinki Criteria for Diagnosis and Attribution 2014 (Wolff et al., Scand J Work Environ Health 2016)
ATS 2014 — Chronic Beryllium Disease — ATS Official Statement (Balmes et al., Am J Respir Crit Care Med 2014)
Practice Pulmonary questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.